Quest Laboratories Share Price Today | Stock Price & Quest Laboratories Share Screener
Track the current Quest Laboratories share price and stock price live with TickJournal's free stock screener. Check Quest Laboratories 52-week for the annual price range and momentum. Use the Quest Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Quest Laboratories opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹114 and net income of ₹15, with EBITDA of ₹21, an operating margin of 16.0% and a profit margin of 13.2%.
Quest Laboratories Share Price Chart
Track the current stock price of Quest Laboratories with an interactive chart. Analyse QUESTLAB share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Quest Laboratories stock quote in one place.
Quest Laboratories Company Profile - Fundamental Screener
Screen Quest Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for QUESTLAB shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0TNW01017.
Company Details
Classification
Identifiers and Leadership
Quest Laboratories Balance Sheet Screener
Screen QUESTLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹112, down from ₹122 in 2025.
Latest statistics put total assets at ₹112 and shareholder funds at ₹97, with a leverage ratio of 0.21.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
Assets |
||||||
| Total Assets | 112 | 122 | 61 | 47 | 35 | 18 |
| Current Assets | 93 | 107 | 50 | 34 | 27 | 12 |
| Fixed Assets | 15 | 12 | 10 | 10 | 7 | 6 |
Liabilities |
||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 3 | 2 | 3 | 2 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||
| Total Equity | 97 | 82 | 29 | 15 | 10 | 6 |
| Share Capital | 16 | 16 | 12 | 1 | 1 | 1 |
| Reserves & Surplus | 80 | 65 | 17 | 14 | 9 | 5 |
Quest Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Quest Laboratories income statement and profit fundamentals. Analyze QUESTLAB quarterly results. Quest Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-March, revenue was ₹114 and net profit was ₹15, equal to earnings per unit of ₹9.07, at an operating margin of 16%.
In that period expenses were ₹94, interest cost ₹2 and tax ₹3. The next period listed, 2025-March, shows revenue of ₹108 and net profit of ₹14.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||
| Revenue | 114 | 108 | 83 | 62 | 60 | 30 |
| Expenses | 94 | 88 | 67 | 54 | 53 | 29 |
Operating Costs and Margins | ||||||
| EBITDA | 21 | 20 | 16 | 8 | 7 | 2 |
| Operating Profit % | 16.00% | 15.00% | 19.00% | 13.00% | 11.00% | 5.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 0 |
| Interest | 2 | 1 | 1 | 1 | 0 | 0 |
Profit and Earnings | ||||||
| Profit Before Tax | 18 | 19 | 14 | 7 | 6 | 1 |
| Tax | 3 | 5 | 4 | 2 | 2 | 0 |
| Net Profit | 15 | 14 | 10 | 5 | 4 | 1 |
| EPS | 9.07 | 8.28 | 6.16 | 46.76 | 38.05 | 6.07 |
Quest Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen QUESTLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹11.
Over the same period, investing activities provided ₹35 and financing activities used ₹24.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||
| Operating Activities | -11 | -23 | 3 | 4 | 4 | 1 |
| Investing Activities | 35 | -44 | -5 | -4 | -2 | -1 |
Financing and Net Cash | ||||||
| Financing Activities | -24 | 67 | 2 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 1 | 0 |
Quest Laboratories Shareholding Pattern Screener
See Quest Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Quest Laboratories promoter holding and ownership changes for QUESTLAB on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 66.78%, foreign institutions 0.61%, domestic institutions 2.04% and the public 26.98%, spread across 911 shareholders.
The shareholder count was 911 in 2026-Mar, compared with 1,001 in 2025-Mar.
| Item | 2026-Mar | 2025-Mar | 2025-Sept | 2025-Dec | 2024-Mar | 2024-May |
|---|---|---|---|---|---|---|
Promoter Holding | ||||||
| Promoter Holding | 66.78% | 66.21% | 66.78% | 66.78% | 90.36% | 90.36% |
Institutional Investors | ||||||
| FII Holding | 0.61% | 0.00% | 0.00% | 0.61% | 0.00% | 0.00% |
| DII Holding | 2.04% | 0.07% | 0.00% | 1.37% | 0.00% | 0.00% |
Government, Public and Others | ||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 26.98% | 24.35% | 25.50% | 28.37% | 0.00% | 0.00% |
| Other Holding | 3.58% | 9.37% | 7.72% | 2.87% | 9.64% | 9.64% |
| Shareholder Count | 911 | 1,001 | 1,084 | 1,017 | 20 | 23 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Quest Laboratories. Quest Laboratories dividend yield can be compared with peers and other stocks in the market.
Quest Laboratories Stock Index Membership - Nifty & Sensex
See which indices include Quest Laboratories stock. Check QUESTLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Quest Laboratories Market Events Screener - Corporate Actions
Get Quest Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Quest Laboratories stock events that may affect QUESTLAB share price, along with derivatives, futures and options activity and sector gainers.
7 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated May 29, 2026, with a record date of May 29, 2026.
It is followed by Quarterly Result Announcement dated February 13, 2026 and Quarterly Result Announcement dated November 13, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 0.56% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 32.76% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 3.02% |
| 2025-07-24 | 2025-07-24 | Quarterly Result Announcement | NA | 15.92% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -1.43% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 5.97% |
| 2024-09-04 | 2024-09-04 | Annual General Meeting | NA | 0.24% |
Quest Laboratories Competitors Screener - Peer Stocks Comparison
Screen QUESTLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 435,863 | 36.83 | 61,674 | 12.69% | 11,565 | 38.95 |
| Divis Laboratories | 246,660 | 86.00 | 11,067 | 13.95% | 2,568 | 53.27 |
| Torrent Pharmaceuticals | 182,577 | 86.72 | 13,886 | 20.34% | 2,138 | 42.82 |
| Zydus Life Science | 115,910 | 25.96 | 27,658 | 17.64% | 5,026 | 51.33 |
| Cipla | 108,738 | 33.29 | 29,045 | 2.24% | 3,870 | 35.23 |
| Laurus Labs | 106,982 | 98.39 | 6,868 | 22.01% | 890 | 58.13 |
| Mankind Pharma | 103,418 | 50.84 | 14,636 | 14.85% | 1,938 | 59.40 |
| Dr Reddys Laboratories | 102,916 | 32.77 | 35,059 | 3.90% | 4,158 | 62.37 |
| Aurobindo Pharma | 96,203 | 26.41 | 34,145 | 5.56% | 3,503 | 49.32 |
| Lupin | 92,839 | 16.97 | 29,039 | 26.75% | 5,356 | 31.32 |
Quest Laboratories Company Announcements - News & Reports Screener
Screen QUESTLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
Frequently Asked Questions
How is the company valued right now?
The P/E ratio is 15.00, with earnings per unit of ₹9.07. Market capitalisation stands at ₹164.20 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 6 balance sheet periods, 6 income statement periods, 6 cash flow years and 6 shareholding periods. Information is provided for research and is not investment advice.